{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "d1ae2347",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import ollama\n",
    "\n",
    "# Import all scripts\n",
    "import pdf_to_md\n",
    "import analyze_img\n",
    "import analyze_per_llm\n",
    "import chunk_md\n",
    "import vectorize"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "5f04daf6",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2026-01-28 15:55:53,589 - INFO - detected formats: [<InputFormat.PDF: 'pdf'>]\n",
      "2026-01-28 15:55:53,625 - INFO - Going to convert document batch...\n",
      "2026-01-28 15:55:53,626 - INFO - Initializing pipeline for StandardPdfPipeline with options hash e15257d5971d637213ae4eeac3fe7fb5\n",
      "2026-01-28 15:55:53,641 - INFO - Loading plugin 'docling_defaults'\n",
      "2026-01-28 15:55:53,642 - INFO - Registered picture descriptions: ['vlm', 'api']\n",
      "2026-01-28 15:55:53,655 - INFO - Loading plugin 'docling_defaults'\n",
      "2026-01-28 15:55:53,658 - INFO - Registered ocr engines: ['easyocr', 'ocrmac', 'rapidocr', 'tesserocr', 'tesseract']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Converting: /Users/fabiantrost/Mimir/Students/guideline_student_project/snippets/001-024l_S3_Praeoperative-Anaemie_2018-04-abgelaufen.pdf\n",
      "Output folder: /Users/fabiantrost/Mimir/Students/guideline_student_project/snippets/output_1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2026-01-28 15:55:53,951 - INFO - Accelerator device: 'mps'\n",
      "2026-01-28 15:55:56,397 - INFO - Accelerator device: 'mps'\n",
      "2026-01-28 15:55:57,929 - INFO - Accelerator device: 'mps'\n",
      "2026-01-28 15:55:58,332 - INFO - Processing document 001-024l_S3_Praeoperative-Anaemie_2018-04-abgelaufen.pdf\n",
      "2026-01-28 15:57:55,218 - INFO - Finished converting document 001-024l_S3_Praeoperative-Anaemie_2018-04-abgelaufen.pdf in 121.63 sec.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "  Saved: img_1.png\n",
      "  Saved: img_2.png\n",
      "  Saved: img_3.png\n",
      "  Saved: img_4.png\n",
      "  Saved: img_5.png\n",
      "  Saved: img_6.png\n",
      "  Saved: img_7.png\n",
      "  Saved: img_8.png\n",
      "  Saved: img_9.png\n",
      "  Saved: img_10.png\n",
      "  Saved: img_11.png\n",
      "  Saved: img_12.png\n",
      "  Saved: img_13.png\n",
      "  Saved: img_14.png\n",
      "  Saved: img_15.png\n",
      "  Saved: img_16.png\n",
      "  Saved: img_17.png\n",
      "  Saved: img_18.png\n",
      "  Saved: img_19.png\n",
      "  Saved: 001-024l_S3_Praeoperative-Anaemie_2018-04-abgelaufen.md\n",
      "Conversion complete! 19 images extracted.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "PosixPath('/Users/fabiantrost/Mimir/Students/guideline_student_project/snippets/output_1')"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gl_path = \"001-024l_S3_Praeoperative-Anaemie_2018-04-abgelaufen.pdf\"\n",
    "if False: # run only once\n",
    "    pdf_to_md.convert_pdf_to_markdown(gl_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6f2a4549",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2026-01-28 15:59:46,641 - INFO - HTTP Request: POST http://127.0.0.1:11434/api/chat \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "The image is a flowchart that outlines a medical treatment process for chronic kidney disease (CKD). The flowchart is divided into three main sections: \"Eisenmangel\" (Iron Deficiency), \"Anämie der Renal\" (Renal Anemia), and \"Vit. B12 / Folsäuremangel\" (Vitamin B12/Folate Deficiency). Each section has a corresponding color-coded background: blue for Eisenmangel, orange for Anämie der Renal, and green for Vit. B12 / Folsäuremangel.\n",
      "\n",
      "The flowchart begins with the diagnosis of chronic kidney disease (CKD) and proceeds to determine if there is an iron deficiency. If iron deficiency is present, the treatment involves increasing iron intake through oral supplements or intravenous infusions. The next step is to assess for renal anemia, which is defined as a hemoglobin (Hb) level below 12 g/dL and a mean corpuscular volume (MCV) of less than 30 µg/L. If renal anemia is present, the treatment involves increasing iron supplementation or administering medications such as allopurinol to reduce hemoglobin levels.\n",
      "\n",
      "If no iron deficiency or renal anemia is detected, the flowchart proceeds to assess for vitamin B12/folate deficiency. This involves measuring serum levels of vitamin B12 and folate. If low levels are found, treatment may include oral supplements or intravenous infusions of these nutrients.\n",
      "\n",
      "The flowchart also includes a note that the transfusion probability is greater than 10% for all three conditions, indicating that transfusions may be considered in cases where iron deficiency, renal anemia, and vitamin B12/folate deficiency are present. Additionally, there is a mention of \"Eisen-Status\" (Iron Status) with specific ranges for serum iron levels, which are used to determine the need for iron supplementation or transfusion.\n",
      "\n",
      "The flowchart concludes with the label \"MCV erhöht\" (MCV Increased), indicating that an increase in mean corpuscular volume is a goal of treatment for renal anemia. The final step involves the administration of medications such as allopurinol to reduce hemoglobin levels and improve kidney function.\n",
      "\n",
      "Overall, the flowchart provides a structured approach to managing chronic kidney disease by addressing iron deficiency, renal anemia, and vitamin B12/folate deficiency through appropriate treatment strategies.\n"
     ]
    }
   ],
   "source": [
    "# analyze image using granite vision\n",
    "prompt = \"Analyze the content of the image and provide a summary. If its a flowchart, describe all the steps involved.\" #improve prompt or play around with it\n",
    "model = \"granite3.2-vision:2b\" # test different images\n",
    "\n",
    "path = \"output_1/img_10.png\"\n",
    "img_cont = analyze_img.analyze_image(image_path=path, prompt=prompt, model=model)\n",
    "\n",
    "print(img_cont)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "df2e3c89",
   "metadata": {},
   "outputs": [],
   "source": [
    "#include image description into md file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "bee0e6a4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Chunked 001-024l_S3_Praeoperative-Anaemie_2018-04-abgelaufen.md\n",
      "   → 151 chunks created\n",
      "   → Saved to: /Users/fabiantrost/Mimir/Students/guideline_student_project/snippets/output_1/chunks.json\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "## Epidemiologie 8.1.\n",
      "\n",
      "Grundlage für die Definition der Präoperativen Anämie dieser Leitlinie sind die von der WHO definierten Grenzwerte für Anämie auf Meereshöhe in Abhängigkeit von der Population (1):\n",
      "\n",
      "-  Frauen (nicht schwanger): &lt; 12 g/dl\n",
      "-  Frauen (schwanger): &lt; 11 g/dl\n",
      "-  Männer: &lt; 13 g/dl\n",
      "\n",
      "Der WHO-Klassifikation der Anämie folgt auch die in dieser Leitlinie analysierte Evidenz inkl. der internationalen Leitlinie des 'Network for the Advancement of Transfusion Alternatives (NATA)' und ihren Empfehlungen zur Diagnostik, Evaluation und Management der präoperativen Therapie nach GRADE (2).\n",
      "\n",
      "Die durchschnittliche Prävalenz einer Anämie jeglicher Ursache liegt weltweit bei ca. 27 % (3), in Europa allgemein bei ca. 10 % (1) und variiert je nach Population: Bei Frauen wird in Deutschland von einer Anämieprävalenz von 5 - 19 % ausgegangen (1). Für Männer im Alter von 17 - 49 Jahren wird eine Prävalenz der Anämie jedweder Ursache von 1,5 % beschrieben (4). Jedoch steigt die Prävalenz unabhängig vom Geschlecht bis auf 11 % in der Altersgruppe &gt; 65 Jahre bzw. bis zu 26,1 % in der Altersgruppe ≥ 85 Jahre (5).\n",
      "\n",
      "In der Population präoperativer Patienten steigt die Prävalenz der Anämie jedweder Ursache weiter an. Je nach Patientenklientel bzw. Art des operativen Eingriffes werden Prävalenzen zwischen 10,5 und 47,9 % berichtet (6). Im Vordergrund der untersuchten präoperativen Population mit der höchsten präoperativen Anämierate stehen Patienten vor gynäkologischen, vaskulären, kolorektalen, kardiochirurgischen, orthopädischen und urologischen Eingriffen (2, 6).\n"
     ]
    }
   ],
   "source": [
    "# chunk text\n",
    "chunks = chunk_md.chunk_markdown_file(\"output_1/001-024l_S3_Praeoperative-Anaemie_2018-04-abgelaufen.md\", output_path=\"output_1/chunks.json\", max_chunk_size=4096, overlap_percent=0.2) #function might need some debugging/improvements\n",
    "\n",
    "#show histogram of chunk sizes\n",
    "\n",
    "chunk_sizes = [len(chunk['text']) for chunk in chunks]\n",
    "plt.hist(chunk_sizes, bins=20)\n",
    "plt.title(\"Histogram of Chunk Sizes\")\n",
    "plt.xlabel(\"Chunk Size (characters)\")\n",
    "plt.ylabel(\"Frequency\")\n",
    "plt.show()\n",
    "\n",
    "print(chunks[45][\"text\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "531fd33a",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2026-01-28 16:12:02,970 - INFO - HTTP Request: POST http://127.0.0.1:11434/api/chat \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "### **S3-Leitlinie: Diagnostik und Therapie der präoperativen Anämie**\n",
      "**Fachgesellschaft:** Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI) in Kooperation mit AWMF\n",
      "**AWMF-Registernummer:** 001-0024\n",
      "**Version:** 1.0 (Stand: 11.04.2018)\n",
      "**Gültigkeitsbereich:** Ambulant/stationär (präoperative Patienten)\n",
      "\n",
      "---\n",
      "\n",
      "### **Metadaten**\n",
      "- **Titel:** *Diagnostik und Therapie der präoperativen Anämie*\n",
      "- **Fachgesellschaft:** DGAI (federführend), AWMF\n",
      "- **Evidenzgraduierung:** GRADE-System\n",
      "- **Zielgruppe:** Anästhesiologen, Chirurgen, Internisten, Hämatologen\n",
      "\n",
      "---\n",
      "\n",
      "### **Patientenzielgruppe**\n",
      "**Einschlusskriterien:**\n",
      "- Alle elektive/akut operierende Patienten mit **Hämoglobin (Hb) < 12 g/dl (Frauen) / < 13 g/dl (Männer)** oder klinischen Anämiezeichen (z. B. Fatigue, Tachykardie).\n",
      "- **Risikostratifizierung** nach OP-Typ:\n",
      "  - Kardiochirurgie (höchste Priorität)\n",
      "  - Elektive Nicht-Kardio-OP (mittlere Priorität)\n",
      "  - Subgruppen: Geschlecht, Alter, Komorbiditäten (z. B. Niereninsuffizienz).\n",
      "\n",
      "**Ausschlusskriterien:**\n",
      "- Akute Blutung > 24 h vor OP (priorisiert akut-therapeutisch).\n",
      "- Terminales Stadium (Palliativsituation).\n",
      "\n",
      "---\n",
      "\n",
      "### **Haupthandlungsstrang**\n",
      "**1. Screening & Risikostratifizierung**\n",
      "- **Hb-Bestimmung** präoperativ (Standard).\n",
      "- **Epidemiologische Risikofaktoren** identifizieren (z. B. chronische Erkrankungen, Eisenmangel, Niereninsuffizienz).\n",
      "\n",
      "**2. Ätiologische Diagnostik (Algorithmus)**\n",
      "- **Primär:**\n",
      "  - **Eisenmangelanämie** (Ferritin, Transferrin-Sättigung).\n",
      "  - **Vitamin-B₁₂/Folsäuremangel** (MCV, Homocystein, Methylmalonsäure).\n",
      "- **Sekundär:**\n",
      "  - **Renale Anämie** (GFR, EPO-Spiegel).\n",
      "  - **Hämolytische Anämie** (LDH, Haptoglobin, Reticulozytose).\n",
      "  - **Anämie chronischer Erkrankungen** (CRP, IL-6).\n",
      "\n",
      "**3. Therapie (ursachengerecht)**\n",
      "| **Ätiologie**               | **1. Wahl**                          | **2. Wahl**                     | **Notfallmaßnahme**          |\n",
      "|-----------------------------|--------------------------------------|---------------------------------|-------------------------------|\n",
      "| Eisenmangel                 | **Oral** (Fe²⁺-Salze)                | **Parenteral** (Fe-Dextran)      | Erythrozytenkonzentrate (Hb < 7 g/dl) |\n",
      "| Vitamin-B₁₂/Folsäuremangel   | **Folsäure** (5 mg/d)                | **Cyanocobalamin** (1.000 µg)    | –                             |\n",
      "| Renale Anämie               | **EPO** (subkutan) + Eisen           | –                               | –                             |\n",
      "| Hämolytisch                 | Ursachenabklärung (z. B. Autoimmun)  | Kortikosteroide                 | Transfusion                   |\n",
      "| Chronisch-inflammatorisch    | **EPO** (bei Hb < 10 g/dl)            | –                               | –                             |\n",
      "\n",
      "**4. Transfusionsindikation**\n",
      "- **Absolute Indikation:** Hb < 7 g/dl oder symptomatisch (Angina pectoris, Herzinsuffizienz).\n",
      "- **Relative Indikation:** Hb 7–10 g/dl bei kardiochirurgischen Eingriffen.\n",
      "\n",
      "**5. Autologe Blutspende**\n",
      "- **Maschinelle Autotransfusion** bei großen Blutverlusten (> 500 ml).\n",
      "\n",
      "---\n",
      "### **Zentrale Endpunkte**\n",
      "- **Primär:** Vermeidung perioperativer Komplikationen (Infektionen, kardiale Ereignisse).\n",
      "- **Sekundär:** Reduktion der Transfusionsrate, Verbesserung der Lebensqualität.\n",
      "\n",
      "---\n",
      "### **Zentrale Algorithmen**\n",
      "1. **Diagnostik-Algorithmus:**\n",
      "   - **Hb < 12/13 g/dl** → **Ferritin/Transferrin** → **MCV** → **EPO/CRP** → **Haptoglobin/LDH** (bei Verdacht auf Hämolyse).\n",
      "2. **Therapie-Algorithmus:**\n",
      "   - **Eisenmangel** → **Oral** (Priorität) → **Parenteral** (bei Malabsorption).\n",
      "   - **EPO-Therapie** nur bei **renaler/chronisch-inflammatorischer Anämie** + Eisenrepletion.\n",
      "\n",
      "---\n",
      "### **Kritische Subgruppen**\n",
      "- **Ältere Patienten:** Höhere Inzidenz von **Eisenmangel** und **Vitamin-B₁₂-Mangel** → **Routinescreening** auf MCV/Ferritin.\n",
      "- **Frauen:** Eisenmangel häufiger → **Menstruationsanamnese** erfassen.\n",
      "- **Niereninsuffizienz:** **EPO-Resistenz** möglich → **höhere Dosen** oder **parenterales Eisen**.\n",
      "\n",
      "---\n",
      "### **Evidenzlücken & Empfehlungen**\n",
      "- **Keine EPO-Therapie** bei **Eisenmangel** ohne Supplementation (Risiko der EPO-Resistenz).\n",
      "- **Transfusionen vermeiden**, wenn möglich (Assoziation mit Infektionen/Thrombosen).\n",
      "- **Kosteneffizienz:** Orales Eisen > parenteral (außer bei Malabsorption).\n",
      "\n",
      "---\n",
      "### **Literaturhinweise**\n",
      "- **Epidemiologie:** Präoperative Anämie in **30–40 %** der OP-Patienten (höhere Mortalität).\n",
      "- **Risikofaktoren:** Chronische Erkrankungen (COPD, Niereninsuffizienz), Malignome, Adipositas.\n",
      "- **Therapie:** Metaanalysen favorisieren **Eisen + EPO** bei renaler Anämie (aber nur bei Hb < 10 g/dl).\n"
     ]
    }
   ],
   "source": [
    "#summarize guideline\n",
    "\n",
    "#To create a high-quality RAG system, generating a Global Context Summary is a brilliant move. \n",
    "# #his \"Top-Down\" approach allows you to inject metadata into your individual vector chunks \n",
    "# #(e.g., \"In the context of Acute Treatment for COPD...\"), which significantly improves retrieval accuracy when queries are ambiguous\n",
    "\n",
    "prompt=\"\"\"Rolle: Du bist ein leitender medizinischer Redakteur mit Expertise in der Strukturierung von AWMF-Leitlinien.\n",
    "\n",
    "Aufgabe: Analysiere die vorliegende medizinische Leitlinie und erstelle eine hochstrukturierte globale Zusammenfassung. Diese Zusammenfassung dient als \"Context Injector\" für ein RAG-System, um die Einordnung von Einzelabschnitten zu verbessern.\n",
    "\n",
    "Struktur der Antwort:\n",
    "\n",
    "    Metadaten: Titel der Leitlinie, Fachgesellschaft, Registernummer und Gültigkeitsbereich (z.B. ambulant/stationär).\n",
    "\n",
    "    Patientenzielgruppe: Wer genau wird behandelt? (Einschluss-/Ausschlusskriterien).\n",
    "\n",
    "    Haupthandlungsstrang: Eine kurze Beschreibung des empfohlenen Behandlungspfades (vom Screening zur Nachsorge).\n",
    "\n",
    "    Zentrale Paradigmen: Welche grundlegenden Prinzipien ziehen sich durch die gesamte Leitlinie? (z.B. \"Shared Decision Making\", \"Palliative Priorisierung\").\n",
    "\n",
    "    Abkürzungsverzeichnis: Eine Liste der wichtigsten im Dokument verwendeten medizinischen Akronyme und deren Auflösung.\n",
    "\n",
    "Stilvorgabe: Extrem prägnant. Verwende medizinisches Fachvokabular. Vermeide Prosa; nutze Listen. HALTE DICH KURZ UND PRÄGNANT.\n",
    "\n",
    "Dokumentinhalt:\"\"\"  #maybe change prompt and play around\n",
    "\n",
    "\n",
    "\n",
    "#concat chunks into one text\n",
    "full_text = \"\\n\\n\".join([chunk['text'] for chunk in chunks])\n",
    "\n",
    "#truncate text to 30000 characters for analysis\n",
    "text = full_text[:30000]\n",
    "\n",
    "model = \"ministral-3:8b\" #play around with this, try different models (gpt-oss:20b, ministral-3:3b, llama-2:7b, etc ...)\n",
    "global_summary = analyze_per_llm.analyze_text(text=text,\n",
    "    prompt=prompt,\n",
    "    model=model\n",
    ") \n",
    "print(global_summary)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "93ed58c2",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2026-01-28 16:14:22,954 - INFO - HTTP Request: POST http://127.0.0.1:11434/api/chat \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Chunk 45 Contextualized Summary:\n",
      "================================================================================\n",
      "**Zusammenfassung für Vektordatenbank (semantisch optimiert):**\n",
      "\n",
      "Die **Epidemiologie der präoperativen Anämie** (Abschnitt 8.1) stützt sich auf **WHO-Grenzwerte** (Hb < 12 g/dl bei Frauen, < 13 g/dl bei Männern) und zeigt eine **globale Prävalenz von 27 %**, in Europa bei **~10 %**, mit **geschlechtsspezifischen Unterschieden** (Frauen: 5–19 %, Männer 17–49 J.: 1,5 %) und **alterabhängiger Zunahme** (> 65 J.: 11 %, ≥ 85 J.: 26,1 %). **Präoperative Patienten** weisen eine **erhöhte Inzidenz von 10,5–47,9 %** auf, besonders bei **kardiochirurgischen, orthopädischen, gynäkologischen und vaskulären Eingriffen** – ein **kritischer Risikofaktor** für perioperative Komplikationen (vgl. Leitlinien-Ziel: Vermeidung kardialer/infektiologischer Ereignisse). Die Daten korrelieren mit der **NATA-Leitlinie** und unterstreichen die **Notwendigkeit einer frühzeitigen Diagnostik** (Hb-Bestimmung + ätiologische Abklärung) zur **Therapieoptimierung** (z. B. Eisenrepletion bei Mangel, EPO bei renaler Anämie) und **Transfusionsvermeidung**.\n",
      "\n",
      "---\n",
      "**Semantische Keywords für Vektorsuche:**\n",
      "- *WHO-Anämie-Grenzwerte* (Hb < 12/13 g/dl, Alter/Geschlecht)\n",
      "- *Prävalenz präoperativ* (10,5–47,9 %, kardiochirurgisch/orthopädisch)\n",
      "- *Risikogruppen* (Alter >65 J., ≥85 J.: 26,1 %; Frauen: 5–19 %)\n",
      "- *NATA-Leitlinie* (internationale Evidenz, GRADE-Klassifikation)\n",
      "- *Leitlinienziel* (Komplikationsvermeidung, Transfusionsreduktion)\n",
      "- *Ätiologische Abklärung* (Eisenmangel, renale Anämie, chronisch-inflammatorisch)\n",
      "- *Therapieprioritäten* (Eisen > EPO, Malabsorption → parenteral)\n",
      "\n",
      "---\n",
      "**Kontext zur Leitlinie:**\n",
      "Der Abschnitt **verankert epidemiologische Daten** als Grundlage für die **Risikostratifizierung** (Kap. 1) und **therapeutische Empfehlungen** (Kap. 3), insbesondere bei **Subgruppen mit hoher Prävalenz** (z. B. ältere Patienten, kardiochirurgische Risikopatienten). Die **Höhe der Prävalenz** rechtfertigt die **priorisierte Hb-Bestimmung** und **ursachenspezifische Therapie** (z. B. Eisen bei Frauen, EPO bei Niereninsuffizienz) zur **Reduktion perioperativer Mortalität/Morbidität**.\n",
      "\n",
      "================================================================================\n",
      "\n",
      "Original chunk preview (first 200 chars):\n",
      "## Epidemiologie 8.1.\n",
      "\n",
      "Grundlage für die Definition der Präoperativen Anämie dieser Leitlinie sind die von der WHO definierten Grenzwerte für Anämie auf Meereshöhe in Abhängigkeit von der Population (...\n"
     ]
    }
   ],
   "source": [
    "# use global summary together with content of single chunk (here chunk[45] as example and write a summary meant for vectorization)\n",
    "\n",
    "chunk_index = 45\n",
    "chunk_content = chunks[chunk_index]['text']\n",
    "\n",
    "# Create a prompt that combines global context with chunk content\n",
    "contextualized_prompt = f\"\"\"Rolle: Du bist ein medizinischer Dokumentationsexperte.\n",
    "\n",
    "Aufgabe: Erstelle eine kontextualisierte Zusammenfassung dieses Abschnitts für ein Vektordatenbank-System.\n",
    "\n",
    "Globaler Kontext der Leitlinie:\n",
    "{global_summary}\n",
    "\n",
    "Abschnittsinhalt:\n",
    "{chunk_content}\n",
    "\n",
    "Anweisung: Schreibe eine prägnante Zusammenfassung (2-4 Sätze), die:\n",
    "1. Den Abschnittsinhalt im Kontext der Gesamtleitlinie einordnet\n",
    "2. Die wichtigsten Informationen hervorhebt\n",
    "3. Medizinisch präzise ist\n",
    "4. Für semantische Suche optimiert ist\"\"\"\n",
    "\n",
    "# Generate contextualized summary using direct ollama call\n",
    "model = \"ministral-3:8b\"\n",
    "response = ollama.chat(\n",
    "    model=model,\n",
    "    messages=[\n",
    "        {\n",
    "            'role': 'user',\n",
    "            'content': contextualized_prompt\n",
    "        }\n",
    "    ]\n",
    ")\n",
    "contextualized_summary = response['message']['content']\n",
    "\n",
    "print(f\"Chunk {chunk_index} Contextualized Summary:\")\n",
    "print(\"=\"*80)\n",
    "print(contextualized_summary)\n",
    "print(\"\\n\" + \"=\"*80)\n",
    "print(f\"\\nOriginal chunk preview (first 200 chars):\")\n",
    "print(chunk_content[:200] + \"...\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "f1b7736f",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2026-01-28 16:16:44,610 - INFO - HTTP Request: POST http://127.0.0.1:11434/api/embed \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Vectorized Contextualized Summary:\n",
      "Vector shape: (768,)\n",
      "First 10 dimensions: [-0.0626595   0.03329423 -0.07802938  0.01028506  0.05992523 -0.00897435\n",
      "  0.03463752  0.03080464  0.04091489  0.03770637]\n"
     ]
    }
   ],
   "source": [
    "#vectorize contextualized_summary and show vector as np.array\n",
    "vector = vectorize.vectorize(contextualized_summary, model = \"granite-embedding:278m\") #test different embedding models\n",
    "print(\"Vectorized Contextualized Summary:\")\n",
    "print(f\"Vector shape: {vector.shape}\")\n",
    "print(f\"First 10 dimensions: {vector[:10]}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3c635792",
   "metadata": {},
   "outputs": [],
   "source": [
    "# try retrival via vector distance (cosine similarity, geometric etc.)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
